Oral Hypoxia-Inducible Factor 2α Inhibitor Belzutifan in Ocular von Hippel-Lindau Disease: Subgroup Analysis of the Single-Arm Phase 2 LITESPARK-004 Study.

Autor: Wiley HE; Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland., Srinivasan R; Molecular Cancer Section, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Maranchie JK; Department of Urology, University of Pittsburgh/UPMC, Pittsburgh, Pennsylvania., Chhablani J; Department of Ophthalmology, University of Pittsburgh/UPMC, Pittsburgh, Pennsylvania., Iversen ABB; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Kruse A; Department of Ophthalmology, Aalborg University Hospital, Aalborg, Denmark., Jonasch E; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Gombos DS; Section of Ophthalmology, Department of Head & Neck Surgery, Division of Surgery, MD Anderson Cancer Center, Houston, Texas., Else T; Department of Internal Medicine, MEND, Division of Genetic Medicine, University of Michigan, Ann Arbor, Michigan., Demirci H; Department of Ophthalmology, University of Michigan, Ann Arbor, Michigan., Maughan BL; Division of Medical Oncology at Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Hartnett ME; Department of Ophthalmology, University of Utah, Salt Lake City, Utah; Department of Ophthalmology, Byers Eye Institute at Stanford University, Palo Alto, California., Coleman HR; VOIANT (Independent Reading Center), Boston, Massachusetts; Department of Ophthalmology, Columbia University, New York, NY., Fu W; Merck & Co., Inc., Rahway, New Jersey., Perini RF; Merck & Co., Inc., Rahway, New Jersey., Liu Y; Merck & Co., Inc., Rahway, New Jersey., Linehan WM; Urologic Oncology Branch, National Cancer Institute, Bethesda, Maryland., Chew EY; Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland. Electronic address: echew@nei.nih.gov.

Publikováno v: Ophthalmology [Ophthalmology] 2024 Nov; Vol. 131 (11), pp. 1324-1332. Date of Electronic Publication: 2024 Jun 06.

Genotype-phenotype correlation of ocular von Hippel-Lindau disease in Koreans.

Autor: Hwang, Sungsoon¹ (AUTHOR), Kang, Se Woong¹ (AUTHOR), Kim, Jong-Won^2,3 (AUTHOR), Kim, Sang Jin¹ (AUTHOR) sangjin.kim.md@gmail.com

Publikováno v: PLoS ONE. 10/7/2024, Vol. 19 Issue 10, p1-11. 11p.

Prevalence of Neurological Symptoms and Imaging Findings in Von Hippel–Lindau Patients Referred to Rasool Akram Hospital, 2018–2021.

Autor: Javadi, Seyed Hamidreza¹ (AUTHOR), Habibi, Seyed Amir Hassan¹ (AUTHOR), Sedaghat, Ahad² (AUTHOR), Naseripour, Masood² (AUTHOR), Yousefi, Mohammad^3,4 (AUTHOR)

Publikováno v: Journal of Kidney Cancer & VHL. 2024, Vol. 11 Issue 2, p1-6. 6p.

A case study of an older adult with severe anemia refusing blood transfusion.

Autor: Thomas CM, Coleman HR, Morritt Taub L

Publikováno v: Journal of the American Academy of Nurse Practitioners; Jan2007, Vol. 19 Issue 1, p43-48, 6p

Investigation of germline VHL variants in Iranian patients with retinal capillary hemangioblastoma and genotype-phenotype analysis.

Autor: Naseripour, Masood^1,2 (AUTHOR), Azimi, Fatemeh¹ (AUTHOR), Talebi, Said³ (AUTHOR), Mirshahi, Reza¹ (AUTHOR), Kiaee, Reza¹ (AUTHOR), Sedaghat, Ahad¹ (AUTHOR), Zohre, Ataei Kachoei³ (AUTHOR), Khakpour, Golnaz^1,3 (AUTHOR) khakpour.g@iums.ac.ir

Publikováno v: Ophthalmic Genetics. Jun2023, Vol. 44 Issue 3, p211-217. 7p.